Cholangiocyte bile salt transporters in cholesterol gallstone-susceptible and resistant inbred mouse strains.

Journal of Gastroenterology and Hepatology
Julia J LiuN F Larusso

Abstract

We investigated the dietary and gender influences on the expression and functionality of cholangiocyte bile salt transporters and development of biliary hyperplasia in cholesterol gallstone-susceptible C57L/J and resistant AKR/J mice. C57L and AKR mice were fed chow, a lithogenic diet, or a cholic acid-containing diet for 14 days. Expression of cholangiocyte bile salt transporter proteins ASBT (SLC10A2), ILBP (FABP6), and MRP3 (ABCC3) were studied by Western blot analysis. Taurocholate uptake studies were performed using microperfusion of isolated bile duct units. The pre- and post-perfusion taurocholate concentrations were analyzed by high performance liquid chromatography. Biliary proliferation in liver sections was scored. The lithogenic diet induced ductular proliferation in C57L mice. On chow, SLC10A2 and ABCC3 were overexpressed in male and female C57L compared to AKR mice. A lithogenic diet reduced the expressions of FABP6 in both male and female C57L mice, SLC10A2 in female C57L mice, and ABCC3 in male C57L mice. These alterations in transporter expressions were not associated with changes in taurocholate uptake. The lithogenic diet induced biliary hyperplasia and reduced bile salt transporter expressions in C57L mice. ...Continue Reading

References

Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·B KhanujaB Paigen
Feb 1, 1995·The Journal of Clinical Investigation·B L ShneiderF J Suchy
Dec 1, 1994·Mammalian Genome : Official Journal of the International Mammalian Genome Society·E H BirkenmeierJ I Gordon
Jan 1, 1993·Gastroenterology·J LillienauA F Hofmann
Mar 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R DumaswalaJ E Heubi
Aug 5, 1996·Biochemical and Biophysical Research Communications·E C TorchiaL B Agellon
Feb 12, 1998·The Journal of Clinical Investigation·K N LazaridisN F LaRusso
Feb 11, 1998·Mammalian Genome : Official Journal of the International Mammalian Genome Society·F LammertM C Carey
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M ArreseB L Shneider
May 18, 1999·The Journal of Biological Chemistry·T HirohashiY Sugiyama
Aug 28, 1999·Gastroenterology·J E EverhartK R Maurer
Jan 25, 2000·The Journal of Biological Chemistry·T HirohashiY Sugiyama
Mar 11, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·K OgawaY Sugiyama
Jul 25, 2000·Journal of Hepatology·P SauerW Kramer
Dec 13, 2000·Gastroenterology·A I MasyukN F LaRusso
Oct 27, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G AlpiniG Lesage
Nov 26, 2004·The Journal of Biological Chemistry·Paul A DawsonNazzareno Ballatori
Dec 1, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nazzareno BallatoriNa Li

❮ Previous
Next ❯

Citations

Jun 26, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·S GlaserA Holterman
Mar 18, 2010·Drug Metabolism Reviews·Xinsheng Gu, Jose E Manautou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.